Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors. [electronic resource]
- American journal of physiology. Cell physiology Jul 2007
- C328-36 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0363-6143
10.1152/ajpcell.00560.2006 doi
Acetophenones--pharmacology Amphetamines--pharmacology Benzopyrans--pharmacology Blood Coagulation--drug effects Blood Platelets--drug effects Case-Control Studies Cell Membrane--drug effects Diabetes Mellitus, Type 2--blood Dose-Response Relationship, Drug Glycation End Products, Advanced--metabolism Humans Phosphatidylserines--metabolism Platelet Activation--drug effects Protein Kinase C-delta--antagonists & inhibitors Protein Kinase Inhibitors--pharmacology Receptor, Serotonin, 5-HT2A--drug effects Receptor, Serotonin, 5-HT2C--drug effects Renal Insufficiency, Chronic--blood Ritanserin--pharmacology Serotonin Antagonists--pharmacology Serotonin Receptor Agonists--pharmacology Serum Albumin--metabolism Serum Albumin, Human Time Factors